CALCOCO1 expression has also been found to be altered in CRC and breast cancer (502–504), and this may also be linked to an alteration in the WNT/β-catenin signaling pathways but through an ill-described function of CALCOCO1 in transcription (502, 505–508). This evidence concerns the gene CALCOCO1 and breast cancer.